Fmoc-S-trityl-L-cysteine is a protected cysteine derivative in which the amino group is masked by an Fmoc (9H-fluoren-9-ylmethoxycarbonyl) carbamate and the thiol side chain is protected as an S-trityl thioether, retaining the cysteine backbone with a free carboxyl group. The molecule contains the stereogenic center associated with L-cysteine, and the S-trityl group provides a bulky, hydrophobic protecting group that suppresses thiol oxidation and side reactions while maintaining the thioether functionality during peptide assembly. Fmoc-S-trityl-L-cysteine is used as a stepwise building block for solid-phase peptide synthesis and related peptide chemistry workflows where controlled cysteine side-chain protection supports the preparation of cysteine-containing peptide derivatives.
CAT No: CP00636
CAS No:103213-32-7
Synonyms/Alias:Fmoc-Cys(Trt)-OH;FMOC-S-trityl-L-cysteine;103213-32-7;CHEMBL396414;N-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine;Na-Fmoc-Ng-trityl-L-glutamine;n-[(9h-fluoren-9-ylmethoxy)carbonyl]-s-trityl-l-cystein;Nalpha-Fmoc-S-trityl-L-cysteine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-L-cysteine;(R)-(9H-Fluoren-9-yl)methyl(1-hydroxy-3-(tritylthio)propan-2-yl)carbamate;Fmoc-S-trityl-cys;N-Fmoc-S-trityl-L-cysteine;PubChem10010;Fmoc-S-Trityl-Cys-OH;Fmoc-L-Cys(Trt)-OH;Fmoc-Cys(trt))-OH;AC1L2TFO;AC1Q5QT8;KSC176O9R;47695_ALDRICH;N|A-Fmoc-S-trityl-L-cysteine;SCHEMBL1738641;08503_FLUKA;47695_FLUKA;CTK0H6798
Fmoc-S-trityl-L-cysteine is an Fmoc-protected cysteine derivative in which the thiol side chain is masked as an S-trityl thioether, preserving the L stereochemical configuration at the alpha carbon. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group for controlled amide formation during peptide assembly, alongside a bulky trityl group that modulates sulfur reactivity and suppresses premature thiol participation. The combination of an aromatic carbamate and a thioether-protected side chain yields a stable, chiral amino acid building block with a defined functional handle for later thiol unmasking and subsequent S-functionalization. The presence of orthogonally removable protection supports downstream peptide coupling chemistry, disulfide or thioether-forming transformations, and chiral intermediate preparation for sulfur-containing motifs.
1. Peptide Synthesis
Fmoc-S-trityl-L-cysteine is used in peptide synthesis workflows where cysteine incorporation requires orthogonal protection of the thiol side chain while maintaining an Fmoc strategy for iterative N-terminal deprotection and coupling. The Fmoc group enables standard peptide coupling chemistry at the amino terminus, whereas the S-trityl thioether suppresses thiol oxidation and side reactions during chain elongation. Thiol unmasking after assembly can generate a reactive cysteine residue for disulfide bond formation or selective thioether derivatization, supporting the construction of thiol-containing peptides and cysteine-rich sequences. The stereodefined L-cysteine backbone also supports consistent incorporation into peptide libraries for chemical biology and peptide science applications.
2. Bioconjugation Chemistry
Fmoc-S-trityl-L-cysteine supports bioconjugation and biomolecule labeling strategies that require controlled introduction of sulfur nucleophiles after synthesis or post-modification. The protected thiol functionality, carried as an S-trityl thioether during handling, can be converted to a free thiol under appropriate deprotection conditions to enable conjugation chemistries such as maleimide addition, thiol-disulfide exchange, or thioether formation. The Fmoc-protected amino terminus and the chiral cysteine framework facilitate preparation of peptide-based linkers and defined conjugation handles with stereochemical fidelity at the alpha carbon. Downstream conjugate generation benefits from the ability to time thiol activation, reducing undesired oxidation and improving compatibility with sensitive biomolecular workflows.
3. Peptidomimetics Construction
Fmoc-S-trityl-L-cysteine is applicable to peptidomimetic and sulfur-functional scaffold construction where cysteine-like stereochemistry and sulfur chemistry are required for receptor-binding motif mimicry. The amino acid derivative provides a protected nitrogen for controlled coupling into larger frameworks, while the S-trityl group functions as a stable sulfur-protecting group that can be selectively removed to introduce thiol-derived substituents. Thiol release can enable formation of disulfide-constrained analogs, thioether substituents, or other sulfur-containing functional groups that influence conformational behavior and molecular recognition. The resulting sulfur-bearing intermediates can be carried into SAR studies and medicinal chemistry campaigns focused on cysteine-reactive or disulfide-stabilized motifs.
4. Side-Chain Functionalization
Fmoc-S-trityl-L-cysteine is suitable for side-chain functionalization routes that leverage the orthogonal protection pattern to stage sulfur chemistry with minimized side reactions. The S-trityl thioether masks the cysteine thiol during earlier synthetic steps, allowing selective chemistry at the amino acid backbone or N-protecting group without uncontrolled thiol reactivity. Thiol unmasking can then enable targeted installation of electrophiles or sulfur-based substituents, generating defined thiofunctional derivatives for further synthetic elaboration. The chiral cysteine core supports stereochemically consistent downstream intermediates for heteroatom-functional building blocks used in fine chemical synthesis and advanced amino acid derivative manufacturing.
5. Pharmaceutical Intermediate Preparation
Fmoc-S-trityl-L-cysteine can serve as a manufacturing intermediate for the preparation of protected cysteine units used in peptide-like active ingredient synthesis and process-scale fine chemical production. The Fmoc carbamate provides a robust N-protection handle compatible with peptide coupling sequences, while the S-trityl group offers sulfur protection that can be engineered into a controlled deprotection-to-functionalization sequence. The defined L stereochemistry and sulfur functional group staging support reproducible generation of cysteine-containing intermediates used for further derivatization into drug-like scaffolds, linker segments, or processable peptide fragments. Industrial relevance arises from its role as a chiral, protected amino acid building block that integrates protection strategy with downstream functional group conversion in applied manufacturing routes.
6. Process Chemistry Intermediate
Fmoc-S-trityl-L-cysteine is employed in process chemistry contexts where orthogonally protected amino acid derivatives are required to manage reactivity during multi-step synthesis. The combination of an Fmoc-protected amino group and an S-trityl-protected sulfur center supports stepwise control over deprotection and coupling events, reducing the likelihood of premature thiol oxidation or side reactions. The aromatic protecting groups contribute to predictable handling and transformation behavior, enabling design of synthetic sequences that separate N-terminal activation from later thiol functionalization. The resulting intermediate can be used to prepare cysteine-containing peptide building blocks, sulfur-functional fragments, and chiral intermediates that feed into specialty chemical production and industrial peptide manufacturing workflows.
2. Emu oil in combination with other active ingredients for treating skin imperfections
4. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.